Big news from AASLD President Saul J. Karpen at #TLM26!
AASLD is launching the Liver Network of Excellence, a new nationwide initiative to transform liver care through collaboration, shared data & continuous learning.
📅 Expressions of interest are due Jan. 8, 2027.
🔗 www.aasld.org/liverNOE
AASLD is launching the Liver Network of Excellence, a new nationwide initiative to transform liver care through collaboration, shared data & continuous learning.
📅 Expressions of interest are due Jan. 8, 2027.
🔗 www.aasld.org/liverNOE
November 7, 2026 at 12:15 AM
Big news from AASLD President Saul J. Karpen at #TLM26!
AASLD is launching the Liver Network of Excellence, a new nationwide initiative to transform liver care through collaboration, shared data & continuous learning.
📅 Expressions of interest are due Jan. 8, 2027.
🔗 www.aasld.org/liverNOE
AASLD is launching the Liver Network of Excellence, a new nationwide initiative to transform liver care through collaboration, shared data & continuous learning.
📅 Expressions of interest are due Jan. 8, 2027.
🔗 www.aasld.org/liverNOE
🏆 Congratulations to all the 2026 AASLD and AASLD Foundation Awards & Honors recipients recognized at this year’s #TLM26 Awards & Honors Gala.
Your dedication to advancing liver research, improving patient care, and strengthening our community continues to move the field forward.
Your dedication to advancing liver research, improving patient care, and strengthening our community continues to move the field forward.
November 8, 2026 at 8:00 PM
🏆 Congratulations to all the 2026 AASLD and AASLD Foundation Awards & Honors recipients recognized at this year’s #TLM26 Awards & Honors Gala.
Your dedication to advancing liver research, improving patient care, and strengthening our community continues to move the field forward.
Your dedication to advancing liver research, improving patient care, and strengthening our community continues to move the field forward.
Introducing AASLD's NEW Hepatocellular Carcinoma #HCC Digital Toolkit! 🎉
Designed to streamline clinical decision-making, this easy-to-navigate resource brings together essential tools for #LiverCancer care in one convenient location:
🔗 Explore the toolkit: https://bit.ly/4fhxJBk
Designed to streamline clinical decision-making, this easy-to-navigate resource brings together essential tools for #LiverCancer care in one convenient location:
🔗 Explore the toolkit: https://bit.ly/4fhxJBk
November 7, 2026 at 9:05 PM
Introducing AASLD's NEW Hepatocellular Carcinoma #HCC Digital Toolkit! 🎉
Designed to streamline clinical decision-making, this easy-to-navigate resource brings together essential tools for #LiverCancer care in one convenient location:
🔗 Explore the toolkit: https://bit.ly/4fhxJBk
Designed to streamline clinical decision-making, this easy-to-navigate resource brings together essential tools for #LiverCancer care in one convenient location:
🔗 Explore the toolkit: https://bit.ly/4fhxJBk
Treatment with both elafibranor & seladelpar led to ALP normalization in the vast majority of patients with PBC who had elevated ALP levels after an incomplete response or intolerance to first-line therapy. @kowdleymd.bsky.social #TLM26
https://www.medpagetoday.com/meetingcoverage/aasld/123768
https://www.medpagetoday.com/meetingcoverage/aasld/123768
New Trials Back Quickly Approved Drugs for Primary Biliary Cholangitis
Results show that biochemical normalization is a 'feasible goal,' researchers say
www.medpagetoday.com
November 7, 2026 at 12:56 AM
Treatment with both elafibranor & seladelpar led to ALP normalization in the vast majority of patients with PBC who had elevated ALP levels after an incomplete response or intolerance to first-line therapy. @kowdleymd.bsky.social #TLM26
https://www.medpagetoday.com/meetingcoverage/aasld/123768
https://www.medpagetoday.com/meetingcoverage/aasld/123768
Day 2 #TLM26: Perspectum is at booth #1055 until 5:00 PM MT. Five posters and one oral presentation this week, from MASLD screening to pediatric autoimmune liver disease. Come and say hello before we pack up.
#Perspectum #AASLD
#Perspectum #AASLD
November 8, 2026 at 10:52 AM
Day 2 #TLM26: Perspectum is at booth #1055 until 5:00 PM MT. Five posters and one oral presentation this week, from MASLD screening to pediatric autoimmune liver disease. Come and say hello before we pack up.
#Perspectum #AASLD
#Perspectum #AASLD
Biotech catalysts today (Thu Nov 5)
$CATX presents at AACR (VMT-α-NET)
$MDGL presents at AASLD (Rezdiffra)
$PCRX data readout
+3 more on the site
Dates from the companies' SEC filings
#Biotech #Stocks
Visit for more info: www.elixstocks.com
Educational only. Not investment advice.
$CATX presents at AACR (VMT-α-NET)
$MDGL presents at AASLD (Rezdiffra)
$PCRX data readout
+3 more on the site
Dates from the companies' SEC filings
#Biotech #Stocks
Visit for more info: www.elixstocks.com
Educational only. Not investment advice.
Biotech catalysts today — ElixStocks
$CATX presents at AACR (VMT-α-NET); $MDGL presents at AASLD (Rezdiffra); $PCRX data readout; $VTRS data readout
elixstocks.com
November 5, 2026 at 12:15 PM
Biotech catalysts today (Thu Nov 5)
$CATX presents at AACR (VMT-α-NET)
$MDGL presents at AASLD (Rezdiffra)
$PCRX data readout
+3 more on the site
Dates from the companies' SEC filings
#Biotech #Stocks
Visit for more info: www.elixstocks.com
Educational only. Not investment advice.
$CATX presents at AACR (VMT-α-NET)
$MDGL presents at AASLD (Rezdiffra)
$PCRX data readout
+3 more on the site
Dates from the companies' SEC filings
#Biotech #Stocks
Visit for more info: www.elixstocks.com
Educational only. Not investment advice.
Congratulations to the NIH team on winning the Academic Debates at #TLM2026! 🏆
We love seeing our former AASLD Emerging Liver Scholars like Islam B. Mohamed, MD, MSc, continue to shine and make their mark in hepatology! 👏
We love seeing our former AASLD Emerging Liver Scholars like Islam B. Mohamed, MD, MSc, continue to shine and make their mark in hepatology! 👏
Congratulations to the NIH team, Wesam Aleyadeh, MD and Islam B. Mohamed, MD, MSc, on taking the win at the #TLM26 Academic Debate! 👏🏆
Thank you to everyone who brought their expertise and perspectives to the discussion!
Thank you to everyone who brought their expertise and perspectives to the discussion!
November 6, 2026 at 11:15 PM
Congratulations to the NIH team on winning the Academic Debates at #TLM2026! 🏆
We love seeing our former AASLD Emerging Liver Scholars like Islam B. Mohamed, MD, MSc, continue to shine and make their mark in hepatology! 👏
We love seeing our former AASLD Emerging Liver Scholars like Islam B. Mohamed, MD, MSc, continue to shine and make their mark in hepatology! 👏
The #TLM26 Pickleball Tournament has come to an end:
🏆 Beginner seed winners: AASLD Fellows and Duke Alumni, Dr. Lindsay King and Dr. Andrew Muir.
🏆 Intermediate seed winners: Yan Wang of Eli Lilly and AnLong Li of Madrigal.
🏆 Advanced seed winners: Ian Valencia and Tal Lohith of Takeda.
🏆 Beginner seed winners: AASLD Fellows and Duke Alumni, Dr. Lindsay King and Dr. Andrew Muir.
🏆 Intermediate seed winners: Yan Wang of Eli Lilly and AnLong Li of Madrigal.
🏆 Advanced seed winners: Ian Valencia and Tal Lohith of Takeda.
November 9, 2026 at 4:30 AM
The #TLM26 Pickleball Tournament has come to an end:
🏆 Beginner seed winners: AASLD Fellows and Duke Alumni, Dr. Lindsay King and Dr. Andrew Muir.
🏆 Intermediate seed winners: Yan Wang of Eli Lilly and AnLong Li of Madrigal.
🏆 Advanced seed winners: Ian Valencia and Tal Lohith of Takeda.
🏆 Beginner seed winners: AASLD Fellows and Duke Alumni, Dr. Lindsay King and Dr. Andrew Muir.
🏆 Intermediate seed winners: Yan Wang of Eli Lilly and AnLong Li of Madrigal.
🏆 Advanced seed winners: Ian Valencia and Tal Lohith of Takeda.
✨ Tonight, we celebrate together! ✨
All AASLD members are invited to the Members’ Reception at the Denver Art Museum from 7:30 - 11:30 PM. Connect with colleagues, celebrate our community, and elevate the evening together! Don’t forget to bring your badge for entry.
All AASLD members are invited to the Members’ Reception at the Denver Art Museum from 7:30 - 11:30 PM. Connect with colleagues, celebrate our community, and elevate the evening together! Don’t forget to bring your badge for entry.
November 7, 2026 at 2:00 AM
✨ Tonight, we celebrate together! ✨
All AASLD members are invited to the Members’ Reception at the Denver Art Museum from 7:30 - 11:30 PM. Connect with colleagues, celebrate our community, and elevate the evening together! Don’t forget to bring your badge for entry.
All AASLD members are invited to the Members’ Reception at the Denver Art Museum from 7:30 - 11:30 PM. Connect with colleagues, celebrate our community, and elevate the evening together! Don’t forget to bring your badge for entry.
#DTIL Precision BioSciences Announces Late-Breaking PBGENE-HBV Data at AASLD The Liver Meeting® 2026 Further Demonstrating cccDNA…
https://www.stocktitan.net/news/DTIL/precision-bio-sciences-announces-late-breaking-pbgene-hbv-data-at-230vpmeh6yup.html?utm_source=stocktitan-bluesky&utm_medium=social
https://www.stocktitan.net/news/DTIL/precision-bio-sciences-announces-late-breaking-pbgene-hbv-data-at-230vpmeh6yup.html?utm_source=stocktitan-bluesky&utm_medium=social
Precision BioSciences Announces Late-Breaking PBGENE-HBV Data at AASLD The Liver Meeting® 2026 Further Demonstrating cccDNA Elimination and Potential to Drive Viral Cure
Stock Titan provides an ultra-fast stock market news feed and multiple tools for traders and investors.
www.stocktitan.net
November 5, 2026 at 12:01 PM
#DTIL Precision BioSciences Announces Late-Breaking PBGENE-HBV Data at AASLD The Liver Meeting® 2026 Further Demonstrating cccDNA…
https://www.stocktitan.net/news/DTIL/precision-bio-sciences-announces-late-breaking-pbgene-hbv-data-at-230vpmeh6yup.html?utm_source=stocktitan-bluesky&utm_medium=social
https://www.stocktitan.net/news/DTIL/precision-bio-sciences-announces-late-breaking-pbgene-hbv-data-at-230vpmeh6yup.html?utm_source=stocktitan-bluesky&utm_medium=social
Stop by the AASLD Foundation booth and show us your throwing arm. Every bullseye earns $25 for the Foundation.
Learn about 2027 funding opportunities, ways to donate, and how to join Club 1950, our highest-impact giving community.
Play, learn, and hit us with your best shot!
Learn about 2027 funding opportunities, ways to donate, and how to join Club 1950, our highest-impact giving community.
Play, learn, and hit us with your best shot!
November 6, 2026 at 7:30 PM
Stop by the AASLD Foundation booth and show us your throwing arm. Every bullseye earns $25 for the Foundation.
Learn about 2027 funding opportunities, ways to donate, and how to join Club 1950, our highest-impact giving community.
Play, learn, and hit us with your best shot!
Learn about 2027 funding opportunities, ways to donate, and how to join Club 1950, our highest-impact giving community.
Play, learn, and hit us with your best shot!
✈️Heading to #TLM26 @aasldnews.bsky.social ?
Join us for a Community Conversation: Pathologists are from Mars🔴, Hepatologists are from Venus 🪐: Hepatic Vascular Disorders - Blocked, Budd-ed, and Baffled
Nov 6, Bluebird Ballroom 3GH, 2-3 pm
& more: hanspopperhepatopathologysociety.org/2026/11/hphs...
Join us for a Community Conversation: Pathologists are from Mars🔴, Hepatologists are from Venus 🪐: Hepatic Vascular Disorders - Blocked, Budd-ed, and Baffled
Nov 6, Bluebird Ballroom 3GH, 2-3 pm
& more: hanspopperhepatopathologysociety.org/2026/11/hphs...
HPHS @ AASLD The Liver Meeting 2026 – Hans Popper Hepatopathology Society
hanspopperhepatopathologysociety.org
November 4, 2026 at 2:15 PM
✈️Heading to #TLM26 @aasldnews.bsky.social ?
Join us for a Community Conversation: Pathologists are from Mars🔴, Hepatologists are from Venus 🪐: Hepatic Vascular Disorders - Blocked, Budd-ed, and Baffled
Nov 6, Bluebird Ballroom 3GH, 2-3 pm
& more: hanspopperhepatopathologysociety.org/2026/11/hphs...
Join us for a Community Conversation: Pathologists are from Mars🔴, Hepatologists are from Venus 🪐: Hepatic Vascular Disorders - Blocked, Budd-ed, and Baffled
Nov 6, Bluebird Ballroom 3GH, 2-3 pm
& more: hanspopperhepatopathologysociety.org/2026/11/hphs...
🐻💙 Strike a pose with the Blue Bear in the Convention Center foyer!
💙 Are you a proud AASLD Foundation supporter? Show your pride! Select the special Foundation frame for your Blue Bear selfie and share it on social media! #AASLDFoundation #TLM26 #ShowYourSupport
💙 Are you a proud AASLD Foundation supporter? Show your pride! Select the special Foundation frame for your Blue Bear selfie and share it on social media! #AASLDFoundation #TLM26 #ShowYourSupport
November 6, 2026 at 9:00 PM
🐻💙 Strike a pose with the Blue Bear in the Convention Center foyer!
💙 Are you a proud AASLD Foundation supporter? Show your pride! Select the special Foundation frame for your Blue Bear selfie and share it on social media! #AASLDFoundation #TLM26 #ShowYourSupport
💙 Are you a proud AASLD Foundation supporter? Show your pride! Select the special Foundation frame for your Blue Bear selfie and share it on social media! #AASLDFoundation #TLM26 #ShowYourSupport
📍 Meet Metabolon at #TLM2026 in Denver!
Visit Booth #1748 to explore how metabolomics supports MASLD/MASH research, fibrosis, biomarker discovery, treatment response and gut–liver axis research.
Let's talk about your research!
#Metabolomics #AASLD
Visit Booth #1748 to explore how metabolomics supports MASLD/MASH research, fibrosis, biomarker discovery, treatment response and gut–liver axis research.
Let's talk about your research!
#Metabolomics #AASLD
November 5, 2026 at 3:28 PM
📍 Meet Metabolon at #TLM2026 in Denver!
Visit Booth #1748 to explore how metabolomics supports MASLD/MASH research, fibrosis, biomarker discovery, treatment response and gut–liver axis research.
Let's talk about your research!
#Metabolomics #AASLD
Visit Booth #1748 to explore how metabolomics supports MASLD/MASH research, fibrosis, biomarker discovery, treatment response and gut–liver axis research.
Let's talk about your research!
#Metabolomics #AASLD
i don't have fatty liver disease but thank you for your concern! did you know that they're changing the name of the condition btw? turns out that changing language to be non-stigmatizing is actually important! www.aasld.org/new-masld-no...
New MASLD Nomenclature | AASLD
No more NAFLD! Steatotic Liver Disease is the overarching term; NAFLD is now MASLD.
www.aasld.org
November 8, 2026 at 9:17 PM
i don't have fatty liver disease but thank you for your concern! did you know that they're changing the name of the condition btw? turns out that changing language to be non-stigmatizing is actually important! www.aasld.org/new-masld-no...
The AASLD Foundation is proud to recognize the 96 Abstract Travel Awardees receiving funding to attend TLM26. This year's awardees include 20 Posters of Distinction, 41% First-time presenters, and 21 Countries represented. Join us in congratulating this year's awardees!
#TLM26
#TLM26
November 5, 2026 at 5:30 PM
The AASLD Foundation is proud to recognize the 96 Abstract Travel Awardees receiving funding to attend TLM26. This year's awardees include 20 Posters of Distinction, 41% First-time presenters, and 21 Countries represented. Join us in congratulating this year's awardees!
#TLM26
#TLM26
Day two at #TLM26: three posters in Poster Session II, Fri Nov 6, 1:00 to 2:00 PM MT. #2329 cT1 in the MASLD screening pathway, #2422 an MRI cirrhosis risk model, #2443 liver and heart MRI in hypertension. Booth #1055 all week.
#Perspectum #AASLD
#Perspectum #AASLD
November 6, 2026 at 9:59 AM
Day two at #TLM26: three posters in Poster Session II, Fri Nov 6, 1:00 to 2:00 PM MT. #2329 cT1 in the MASLD screening pathway, #2422 an MRI cirrhosis risk model, #2443 liver and heart MRI in hypertension. Booth #1055 all week.
#Perspectum #AASLD
#Perspectum #AASLD
New Blood Test Accurately Stages Liver Disease
New Blood Test Accurately Stages Liver Disease
An experimental blood test precisely determines the extent of patients' chronic liver disease, researchers reported on Thursday at the AASLD meeting in Denver. The test's performance on routine blood samples matched that of magnetic resonance elastography, the most accurate...
dlvr.it
November 6, 2026 at 4:22 PM
New Blood Test Accurately Stages Liver Disease
Brii Bio Unveils Promising Phase 2 Trial Results for HBV Treatment Strategies#USA#Denver#Brii_Bio#BRII-179#HBV_Treatment
Brii Bio Unveils Promising Phase 2 Trial Results for HBV Treatment Strategies
Brii Bio recently shared groundbreaking data from its Phase 2 studies on BRII-179, showcasing its role in enhancing HBV treatments at AASLD 2026.
third-news.com
November 6, 2026 at 12:21 AM
Brii Bio Unveils Promising Phase 2 Trial Results for HBV Treatment Strategies#USA#Denver#Brii_Bio#BRII-179#HBV_Treatment